The update brings a low-latency profile, speeds up search, and patches hundreds of flaws.

Companies are investing in AI agents and cutting staff, but talented professionals will find new opportunities.

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) were ...

Akeso has announced compelling Phase II trial results for ligufalimab in combination therapy for frontline acute myeloid ...

Brice Matthews, a Houston native, was able to share a special Father's Day moment with his dad Stephen before Sunday's game.

If approved, ozekibart would become the first and only approved systemic therapy for patients with unresectable or metastatic conventional chondrosarcoma, a rare cancer arising in the cartilage cells ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind ...

PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED ...

Kent paceman Matt Milnes takes five wickets to help his side beat Middlesex by 49 runs in the County Championship.

Summit Therapeutics Inc. SMMT stock is down on Monday following the recent announcement regarding the clinical trial results of ivonescimab on Sunday. The recent phase 3 HARMONi-6 trial results for ...

BALTIMORE—For the first time since May 16th, Gunnar Henderson is leading off for the Orioles. Henderson, who’s in a 1-for-19 ...

NANJING -- Data that would take 699 days to transmit over the traditional Internet was transferred in just 1.6 hours on a testbed for China's future networks. China's first national science and ...